The CDR2L Antibody (PAC008353) is a high-quality polyclonal antibody designed for research involving CDR2L, a neuronal protein involved in neurological disorders. This antibody, produced in rabbits, demonstrates strong reactivity with human samples and is validated for use in various applications including Western blotting.CDR2L is a neuronal antigen associated with paraneoplastic cerebellar degeneration, a rare neurological disorder characterized by immune-mediated damage to the cerebellum. The CDR2L antibody binds specifically to the CDR2L protein, enabling its detection and analysis in neuronal cells and tissues.
This makes it an ideal tool for studies exploring the role of CDR2L in neurological diseases and disorders.Understanding the function and expression of CDR2L is crucial for unraveling the mechanisms underlying paraneoplastic cerebellar degeneration and other related conditions. The CDR2L Antibody provides researchers with a reliable means to investigate the role of CDR2L in neurological disorders, potentially leading to advancements in diagnosis and treatment for affected individuals.
